世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

心臓カテーテル＆ガイドワイヤーの市場規模、シェア、動向分析レポート：製品別（心臓カテーテル、心臓ガイドワイヤー）、エンドユーザー別（病院、ASC）、地域別（MEA、APAC、EU）、およびセグメント予測、2022年～2030年


Cardiac Catheters & Guidewires Market Size, Share & Trends Analysis Report By Product (Cardiac Catheters, Cardiac Guidewires), By End-use (Hospitals, ASCs), By Region (MEA, APAC, EU), And Segment Forecasts, 2022 - 2030

心臓カテーテル＆ガイドワイヤー市場の成長と傾向 グランドビューリサーチ社の最新レポートによると、心臓カテーテル＆ガイドワイヤーの世界市場規模は、2022年から2030年にかけて7.56%のCAGRを記録し、2030年... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ 		2022年9月16日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら 		110 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

心臓カテーテル＆ガイドワイヤー市場の成長と傾向

グランドビューリサーチ社の最新レポートによると、心臓カテーテル＆ガイドワイヤーの世界市場規模は、2022年から2030年にかけて7.56%のCAGRを記録し、2030年までに249億2000万ドルに達すると予想されています。この業界は、高齢者人口の増加、市場における代替品の不足、世界的な糖尿病発症率の上昇、技術の進歩などにより成長すると予想されます。糖尿病患者は、高コレステロール、高血圧、心臓病、脳卒中など、特定の健康状態になりやすいと言われています。また、長期にわたる糖尿病は、心臓の筋肉を直接制御する血管や神経にダメージを与えます。このため、心血管疾患（CVD）を発症する可能性も高くなります。

さらに、糖尿病を患っている人は、非常に若くして心臓病や脳卒中を発症する傾向もあります。さらに、糖尿病は肥満を引き起こし、その結果、CVDの素因を増加させます。糖尿病の発症率の高さは、世界中でCVDの有病率が上昇している大きな要因の一つです。例えば、米国糖尿病協会によると、約3,730万人のアメリカ人が糖尿病を患っていると推定され、これは全人口の約11.3%にあたります。また、国際糖尿病連盟の第10版によると、全世界で5億3,700万人が糖尿病を患っており、2045年には7億人に達すると予想されています。また、近年では、カリブ海地域、中東地域、中南米地域、太平洋諸島の一部の国々が世界で最も高い糖尿病罹患率を示しています。

さらに、心臓カテーテル＆ガイドワイヤー装置の技術的進歩は、疾患のリスクが高い患者を特定する際に臨床医をサポートすることができ、これは業界の成長に拍車をかけると予想されます。例えば、2022年2月に、メドトロニックは、一般的な心拍障害の治療のための小児患者用の冷凍アブレーション心臓カテーテルのFDA拡張承認を受けた。したがって、そのような製品の発売は、成長の機会を提供します。COVID-19のパンデミックは、外科手術量の減少により、業界にマイナスの影響を及ぼした。しかし、制限の緩和により、各国は選択的手術を再開しており、予測期間中も業界の成長が続くと思われます。

心臓カテーテル＆ガイドワイヤー市場レポートハイライト

- 心臓カテーテル部門は、技術的に高度な製品の導入、冠動脈インターベンション手術数の増加、糖尿病発症率の増加により、2021年の業界をリードした

- 病院の最終用途セグメントは、慢性疾患の有病率の増加、老年人口の急増、カテーテルの技術的進歩により、予測期間中に業界をリードすることが予想される

- アジア太平洋地域は、予測期間中、最も速いCAGRを記録すると予想されます。意識レベルの向上、可処分所得の増加、慢性疾患の発生率の上昇が、この地域の成長を後押しする主な要因となっています。

- 国際的な企業が数多く存在するため、競争は激化しています。



ページTOPに戻る


目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Product
1.1.2 End-use
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.7.1 Commodity Flow Analysis (Model 1)
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.2 Volume Price Analysis (Model 2)
1.7.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Cardiac Catheters & Guidewires Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Rising Prevalence Of Cardiovascular Diseases (CVDs)
3.5.1.2 Rising Incidence Of Diabetes Across The Globe
3.5.1.3 Favorable Reimbursement Policies For Coronary Intervention Procedures
3.5.2 Market Restraints Analysis
3.5.2.1 Minimal Use Of Ivus Catheters In The Developing Countries
3.5.2.2 Lack Of Skilled Professionals In The Low- And Middle-Income Countries
3.5.2.3 Stringent Regulatory Policies Related To The Product Approval
3.5.3 Market Opportunities Analysis
3.5.3.1 Development Of Specialized Devices And Treatment Techniques
3.5.3.2 Launch Of New Product Lines In The Market
3.6 Cardiac Catheters & Guidewires: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s Five Forces
3.6.2 Swot Analysis, By PEST
3.7 Impact Of Covid-19 On Market & Post Pandemic Insights
Chapter 4 Cardiac Catheters & Guidewires Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1 Definition And Scope
4.2 Product Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Cardiac Catheters & Guidewires Market, By Product, 2018 To 2030
4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
4.5.1 Cardiac Catheters
4.5.1.1 Cardiac Catheters Market, 2018-2030 (USD Million)
4.5.1.2 Electrophysiology Catheters
4.5.1.2.1 Electrophysiology Catheters Market, 2018-2030 (USD Million)
4.5.1.3 PTCA Balloons Catheters
4.5.1.3.1 PTCA Balloons Catheters Market, 2018-2030 (USD Million)
4.5.1.4 Ivus Catheters
4.5.1.4.1 Ivus Catheters Market, 2018-2030 (USD Million)
4.5.1.5 Pta Balloons Catheters
4.5.1.5.1 Pta Balloons Catheters Market, 2018-2030 (USD Million)
4.5.1.6 Guide Extension Catheter
4.5.1.6.1 Guide Extension Catheter Market, 2018-2030 (USD Million)
4.5.1.7 Others
4.5.2 Cardiac Guidewires
4.5.2.1 Cardiac Guidewires Market, 2018-2030 (USD Million)
Chapter 5 Cardiac Catheters & Guidewires Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)
5.1 Definition And Scope
5.2 End-Use Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Cardiac Catheters & Guidewires Market, By End-Use, 2018 To 2030
5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
5.5.1 Hospitals
5.5.1.1 Hospitals Market, 2018-2030 (USD Million)
5.5.2 Clinics
5.5.2.1 Clinics Market, 2018-2030 (USD Million)
5.5.3 Ambulatory Surgical Centers
5.5.3.1 Ambulatory Surgical Centers Market, 2018-2030 (USD Million)
Chapter 6 Cardiac Catheters & Guidewires Market: Regional Market Analysis, By Product And By End-Use, 2018 - 2030 (USD Million)
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2021 & 2030
6.3 Regional Market Dashboard
6.4 Regional Market Snapshot
6.5 Market Size, & Forecasts, Volume, And Trend Analysis, 2021 To 2030
6.6 North America
6.6.1 North America Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.6.2 U.S.
6.6.2.1 U.S. Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.6.3 Canada
6.6.3.1 Canada Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7 Europe
6.7.1 Europe Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.2 U.K.
6.7.2.1 U.K. Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.3 Germany
6.7.3.1 Germany Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.4 France
6.7.4.1 France Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.5 Italy
6.7.5.1 Italy Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.6 Spain
6.7.6.1 Spain Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8 Asia Pacific
6.8.1 Asia Pacific Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.2 Japan
6.8.2.1 Japan Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.3 China
6.8.3.1 China Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.4 India
6.8.4.1 India Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.5 Australia
6.8.5.1 Australia Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.6 South Korea
6.8.6.1 South Korea Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9 Latin America
6.9.1 Latin America Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9.2 Brazil
6.9.2.1 Brazil Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9.3 Mexico
6.9.3.1 Mexico Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9.4 Argentina
6.9.4.1 Argentina Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9.5 Colombia
6.9.5.1 Colombia Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.10 MEA
6.10.1 MEA Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.10.2 South Africa
6.10.2.1 South Africa Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.10.3 Saudi Arabia
6.10.3.1 Saudi Arabia Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.10.4 UAE
6.10.4.1 UAE Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
Chapter 7 Cardiac Catheters & Guidewires Market - Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 Key Company Market Share Analysis, 2021
7.3.2 Major Deals And Strategic Alliances
7.3.2.1 New Product Launch
7.3.2.2 Expansion
7.3.2.3 Acquisition
7.3.3 Market Entry Strategies
7.4 Company Profiles
7.4.1 Abbott
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Boston Scientific Corporation
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 Getinge AB
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 Biosense Webster, Inc (Part of Johnson & Johnson)
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 MicroVention (Terumo Corporation)
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 BIOTRONIK SE & Co. KG
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.6.4 Strategic initiatives
7.4.7 Medtronic
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.7.4 Strategic initiatives
7.4.8 CORDIS (A, Cardinal Health Company)
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.9 QXMédical
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Product benchmarking
7.4.9.4 Strategic initiatives
7.4.10 Teleflex Incorporated
7.4.10.1 Company overview
7.4.10.2 Financial performance
7.4.10.3 Product benchmarking
7.4.10.4 Strategic initiatives
7.4.11 B. Braun
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.12 C. R., Bard, Inc
7.4.12.1 Company overview
7.4.12.2 Financial performance
7.4.12.3 Product benchmarking
7.4.12.4 Strategic initiatives
7.4.13 Cardinal Health
7.4.13.1 Company overview
7.4.13.2 Financial performance
7.4.13.3 Product benchmarking
7.4.13.4 Strategic initiatives
7.4.14 Merit Medical Systems
7.4.14.1 Company overview
7.4.14.2 Financial performance
7.4.14.3 Product benchmarking
7.4.14.4 Strategic initiatives
7.4.15 NIPRO
7.4.15.1 Company overview
7.4.15.2 Financial performance
7.4.15.3 Product benchmarking
7.4.15.4 Strategic initiatives
7.4.16 BrosMed Medical Co., Ltd.
7.4.16.1 Company overview
7.4.16.2 Financial performance
7.4.16.3 Product benchmarking
7.4.16.4 Strategic initiatives

　

ページTOPに戻る


　

Summary

Cardiac Catheters & Guidewires Market Growth & Trends

The global cardiac catheters & guidewires market size is anticipated to reach USD 24.92 billion by 2030, registering a CAGR of 7.56% from 2022 to 2030, according to a new report by Grand View Research, Inc. The industry is expected to grow due to the increasing geriatric population, lack of substitutes in the market, rising incidence of diabetes across the globe, and technological advancements. Diabetic patients are more prone to develop certain health conditions, such as high cholesterol, high blood pressure, heart diseases, and stroke. In addition, long-term diabetes damages the blood vessels and nerves that directly control the heart muscles. This also increases the chances of developing Cardiovascular Diseases (CVDs).

Moreover, people suffering from diabetes also tend to develop heart disease and stroke at a very young age. Furthermore, diabetes triggers the risk of developing obesity, which, in turn, increases the predisposition to CVDs. The high incidence of diabetes is one of the major reasons for the increased prevalence of CVDs across the globe. For instance, according to the American Diabetes Association, around 37.3 million Americans, which was around 11.3% of the total population, were estimated to be suffering from diabetes. Moreover, as per the 10th edition of the International Diabetes Federation, 537 million people worldwide have diabetes, which is anticipated to reach 700 million by 2045. Furthermore, in recent years, the Caribbean, Middle East, Latin America regions, and some nations of the Pacific Islands marked the highest prevalence of diabetes in the world.

Moreover, technological advancements in cardiac catheters & guidewires devices can support clinicians in identifying patients with a high risk of disease, which is anticipated to spur the industry growth. For instance, in February 2022, Medtronic received FDA expanded approval for cryoablation cardiac catheters for pediatric patients for the treatment of a common heart rhythm disorder. Hence, such product launches provide growth opportunities. The COVID-19 pandemic had a negative impact on the industry due to a decrease in surgical procedure volumes. However, due to the ease in restrictions, countries have resumed elective procedures, suggesting that the industry will keep growing during the projected period.

Cardiac Catheters & Guidewires Market Report Highlights

• The cardiac catheters segment led the industry in 2021 due to the introduction of technologically advanced products, rising number of coronary interventional procedures, and increasing incidence of diabetes

• The hospital end-use segment is expected to lead the industry during the forecast years due to the increasing prevalence of chronic diseases, rapidly growing geriatric population, and technological advancements in catheters

• Asia Pacific is expected to register the fastest CAGR over the forecast period. Growing awareness levels, increasing disposable income, and rising incidence of chronic conditions are the key factors boosting the region’s growth

• The industry is highly competitive due to the presence of many international companies



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Product
1.1.2 End-use
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.7.1 Commodity Flow Analysis (Model 1)
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.2 Volume Price Analysis (Model 2)
1.7.2.1 Approach 2: Volume Price Analysis
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Cardiac Catheters & Guidewires Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Key End-Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Rising Prevalence Of Cardiovascular Diseases (CVDs)
3.5.1.2 Rising Incidence Of Diabetes Across The Globe
3.5.1.3 Favorable Reimbursement Policies For Coronary Intervention Procedures
3.5.2 Market Restraints Analysis
3.5.2.1 Minimal Use Of Ivus Catheters In The Developing Countries
3.5.2.2 Lack Of Skilled Professionals In The Low- And Middle-Income Countries
3.5.2.3 Stringent Regulatory Policies Related To The Product Approval
3.5.3 Market Opportunities Analysis
3.5.3.1 Development Of Specialized Devices And Treatment Techniques
3.5.3.2 Launch Of New Product Lines In The Market
3.6 Cardiac Catheters & Guidewires: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s Five Forces
3.6.2 Swot Analysis, By PEST
3.7 Impact Of Covid-19 On Market & Post Pandemic Insights
Chapter 4 Cardiac Catheters & Guidewires Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1 Definition And Scope
4.2 Product Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Cardiac Catheters & Guidewires Market, By Product, 2018 To 2030
4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
4.5.1 Cardiac Catheters
4.5.1.1 Cardiac Catheters Market, 2018-2030 (USD Million)
4.5.1.2 Electrophysiology Catheters
4.5.1.2.1 Electrophysiology Catheters Market, 2018-2030 (USD Million)
4.5.1.3 PTCA Balloons Catheters
4.5.1.3.1 PTCA Balloons Catheters Market, 2018-2030 (USD Million)
4.5.1.4 Ivus Catheters
4.5.1.4.1 Ivus Catheters Market, 2018-2030 (USD Million)
4.5.1.5 Pta Balloons Catheters
4.5.1.5.1 Pta Balloons Catheters Market, 2018-2030 (USD Million)
4.5.1.6 Guide Extension Catheter
4.5.1.6.1 Guide Extension Catheter Market, 2018-2030 (USD Million)
4.5.1.7 Others
4.5.2 Cardiac Guidewires
4.5.2.1 Cardiac Guidewires Market, 2018-2030 (USD Million)
Chapter 5 Cardiac Catheters & Guidewires Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)
5.1 Definition And Scope
5.2 End-Use Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Cardiac Catheters & Guidewires Market, By End-Use, 2018 To 2030
5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
5.5.1 Hospitals
5.5.1.1 Hospitals Market, 2018-2030 (USD Million)
5.5.2 Clinics
5.5.2.1 Clinics Market, 2018-2030 (USD Million)
5.5.3 Ambulatory Surgical Centers
5.5.3.1 Ambulatory Surgical Centers Market, 2018-2030 (USD Million)
Chapter 6 Cardiac Catheters & Guidewires Market: Regional Market Analysis, By Product And By End-Use, 2018 - 2030 (USD Million)
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2021 & 2030
6.3 Regional Market Dashboard
6.4 Regional Market Snapshot
6.5 Market Size, & Forecasts, Volume, And Trend Analysis, 2021 To 2030
6.6 North America
6.6.1 North America Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.6.2 U.S.
6.6.2.1 U.S. Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.6.3 Canada
6.6.3.1 Canada Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7 Europe
6.7.1 Europe Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.2 U.K.
6.7.2.1 U.K. Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.3 Germany
6.7.3.1 Germany Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.4 France
6.7.4.1 France Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.5 Italy
6.7.5.1 Italy Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.7.6 Spain
6.7.6.1 Spain Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8 Asia Pacific
6.8.1 Asia Pacific Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.2 Japan
6.8.2.1 Japan Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.3 China
6.8.3.1 China Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.4 India
6.8.4.1 India Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.5 Australia
6.8.5.1 Australia Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.8.6 South Korea
6.8.6.1 South Korea Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9 Latin America
6.9.1 Latin America Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9.2 Brazil
6.9.2.1 Brazil Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9.3 Mexico
6.9.3.1 Mexico Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9.4 Argentina
6.9.4.1 Argentina Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.9.5 Colombia
6.9.5.1 Colombia Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.10 MEA
6.10.1 MEA Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.10.2 South Africa
6.10.2.1 South Africa Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.10.3 Saudi Arabia
6.10.3.1 Saudi Arabia Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
6.10.4 UAE
6.10.4.1 UAE Cardiac Catheters & Guidewires Market, 2018 - 2030 (USD Million)
Chapter 7 Cardiac Catheters & Guidewires Market - Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 Key Company Market Share Analysis, 2021
7.3.2 Major Deals And Strategic Alliances
7.3.2.1 New Product Launch
7.3.2.2 Expansion
7.3.2.3 Acquisition
7.3.3 Market Entry Strategies
7.4 Company Profiles
7.4.1 Abbott
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Boston Scientific Corporation
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 Getinge AB
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 Biosense Webster, Inc (Part of Johnson & Johnson)
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 MicroVention (Terumo Corporation)
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 BIOTRONIK SE & Co. KG
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.6.4 Strategic initiatives
7.4.7 Medtronic
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.7.4 Strategic initiatives
7.4.8 CORDIS (A, Cardinal Health Company)
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.9 QXMédical
7.4.9.1 Company overview
7.4.9.2 Financial performance
7.4.9.3 Product benchmarking
7.4.9.4 Strategic initiatives
7.4.10 Teleflex Incorporated
7.4.10.1 Company overview
7.4.10.2 Financial performance
7.4.10.3 Product benchmarking
7.4.10.4 Strategic initiatives
7.4.11 B. Braun
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.12 C. R., Bard, Inc
7.4.12.1 Company overview
7.4.12.2 Financial performance
7.4.12.3 Product benchmarking
7.4.12.4 Strategic initiatives
7.4.13 Cardinal Health
7.4.13.1 Company overview
7.4.13.2 Financial performance
7.4.13.3 Product benchmarking
7.4.13.4 Strategic initiatives
7.4.14 Merit Medical Systems
7.4.14.1 Company overview
7.4.14.2 Financial performance
7.4.14.3 Product benchmarking
7.4.14.4 Strategic initiatives
7.4.15 NIPRO
7.4.15.1 Company overview
7.4.15.2 Financial performance
7.4.15.3 Product benchmarking
7.4.15.4 Strategic initiatives
7.4.16 BrosMed Medical Co., Ltd.
7.4.16.1 Company overview
7.4.16.2 Financial performance
7.4.16.3 Product benchmarking
7.4.16.4 Strategic initiatives

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Grand View Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.